Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis.
#PCSM
#ProstateCancer
#uroonc
Complications
Local anaesthesia
PROMS
PrecisionPoint
Prostate cancer
Sepsis
Transperineal biopsy
Journal
BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
pubmed:
16
1
2021
medline:
30
11
2021
entrez:
15
1
2021
Statut:
ppublish
Résumé
To assess the feasibility of local anaesthetic transperineal (LATP) technique using a single-freehand transperineal (TP) access device, and report initial prostate cancer (PCa) detection, infection rates, and tolerability. Observational study of a multicentre prospective cohort, including all consecutive cases. LATP was performed in three settings: (i) first biopsy in suspected PCa, (ii) confirmatory biopsies for active surveillance, and (iii) repeat biopsy in suspected PCa. All patients received pre-procedure antibiotics according to local hospital guidelines. Local anaesthesia was achieved by perineal skin infiltration and periprostatic nerve block without sedation. Ginsburg protocol principles were followed for systematic biopsies including cognitive magnetic resonance imaging-targeted biopsies when needed using the PrecisionPoint™ TP access device. Procedure-related complications and oncological outcomes were prospectively and consecutively collected. A validated questionnaire was used in a subset of centres to collect data on patient-reported outcome measures (PROMs). Some 1218 patients underwent LATP biopsies at 10 centres: 55%, 24%, and 21% for each of the three settings, respectively. Any grade PCa was diagnosed in 816 patients (67%), of which 634 (52% of total) had clinically significant disease. Two cases of sepsis were documented (0.16%) and urinary retention was observed in 19 patients (1.6%). PROMs were distributed to 419 patients, with a 56% response rate (n = 234). In these men, pain during the biopsy was described as either 'not at all' or 'a little' painful by 64% of patients. Haematuria was the most common reported symptom (77%). When exploring attitude to re-biopsy, 48% said it would be 'not a problem' and in contrast 8.1% would consider it a 'major problem'. Most of the patients (81%) described the biopsy as a 'minor or moderate procedure tolerable under local anaesthesia', while 5.6% perceived it as a 'major procedure that requires general anaesthesia'. Our data suggest that LATP biopsy using a TP access system mounted to the ultrasound probe achieves excellent PCa detection, with a very low sepsis rate, and is safe and well tolerated. We believe a randomised controlled trial comparing LATP with transrectal ultrasound-guided biopsy (TRUS) to investigate the relative trade-offs between each biopsy technique would be helpful.
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
311-318Informations de copyright
© 2021 The Authors BJU International © 2021 BJU International Published by John Wiley & Sons Ltd.
Références
Pandian SK, Hammadeh M, Challacombe B, Popert R, Madaan S. History of prostate biopsy. Urol News 2018; 22. Available at; https://www.urologynews.uk.com/features/features/post/history-of-prostate-biopsy-part-1. Accessed January 2021
Grummet JP, Weerakoon M, Huang S et al. Sepsis and “superbugs”: Should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 2014; 114: 384-8
Altok M, Kim B, Patel BB et al. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis 2018; 9: 524-32
Ong WL, Weerakoon M, Huang S et al. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: The Victorian Transperineal Biopsy Collaboration experience. BJU Int 2015; 116: 568-76
EAU-ESUR-ESTRO-SIOG Guidelines on Prostate Cancer, 2019. Available at: https://uroweb.org/wp-content/uploads/EAU-ESUR-ESTRO-SIOG-Guidelines-on-Prostate-Cancer-large-text-V2.pdf. Accessed January 2021.
National Institute for Health and Care Excellence (NICE). Prostate cancer: diagnosis and management NICE guideline (NG131), 2019. Available at: https://www.nice.org.uk/guidance/ng131. Accessed December 2019.
Rosario DJ, Lane JA, Metcalfe C et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ 2012; 344: d7894.
Campbell A, Omer AE, Popert R, Lamb A. Local anaesthetic transperineal prostate (LATP) biopsy using the precision point access system: a step-by-step video. Eur Urol Suppl 2019; 18: e2290
Kum F, Elhage O, Maliyil J, et al. Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting. BJUI 2018; 125: 244-52. https://doi.org/10.1111/bju.14620
Kuru TH, Wadhwa K, Chang RTM et al. Definitions of terms, Processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for enhanced prostate diagnostics. BJU Int 2013; 112: 568-77
Novella G, Ficarra V, Galfano A et al. Pain assessment after original transperineal prostate biopsy using a coaxial needle. Urology 2003; 62: 689-92
Omer A, Lamb AD. Optimizing prostate biopsy techniques. Curr Opin Urol 2019; 29: 578-86
Marra G, Marquis A, Tappero S et al. Transperineal free-hand mpMRI fusion-targeted biopsies under local anesthesia: technique and feasibility from a single-center prospective study. Urology 2020; 140: 122-31
Ganesan V, Dai C, Nyame YA et al. Prognostic significance of a negative confirmatory biopsy on reclassification among men on active surveillance. Urology 2017; 107: 184-9
Pepe P, Cimino S, Garufi A et al. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy. Scand J Urol 2017; 4: 260-3
Marra G, Zhuang J, Beltrami M et al. Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases. BJU Int 2021; 127: 122-30
Ahmed HU, El-Shater Bosaily A, Brown LC et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017; 389: 815-22
Sathianathen N, Omer A, Harriss E et al. Negative predictive value of multi-parametric MRI in detection of clinically significant prostate cancer in the PI-RADS era: a systematic review and meta-analysis. Eur Urol 2020; 78: 402-14
Grummet J, Gorin MA, Popert R et al. “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer Prostatic Dis 2020; 23: 62-5
Gorin MA, Meyer AR, Zimmerman M et al. Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results. World J Urol 2020; 38: 1943-9
Stefanova V, Buckley R, Flax S et al. Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. Prostate cancer detection rate, complications and patient tolerability. J Urol 2019; 201: 1121-6
Wadhwa K, Carmona-Echeveria L, Kuru T et al. Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures. Asian J Androl 2017; 19: 62-6
Vyas L, Acher P, Kinsella J et al. Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases. BJU Int 2014; 114: 32-7
Borghesi M, Ahmed H, Nam R et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol 2017; 71: 353-65
National Institute for Health and Care Excellence (NICE). Interventional procedures programme: Interventional procedure overview of transperineal template biopsy and mapping of the prostate (IP793), 2010. Available at: https://www.nice.org.uk/guidance/ipg364/evidence/transperineal-template-biopsy-of-the-prostate-overview2. Accessed January 2021.
Kum F, Jones A, Nigam R. Factors influencing urinary retention after transperineal template biopsy of the prostate: outcomes from a regional cancer centre. World J Urol 2019; 37: 337-42
Halawi MJ, Caminiti N, Cote MP, Lindsay AD, Williams VJ. The most significant risk factors for urinary retention in fast-track total joint arthroplasty are iatrogenic. J Arthroplasty 2019; 34: 136-9
Miah S, Eldred-Evans D, Simmons LAM et al. Patient reported outcome measures for transperineal template prostate mapping biopsies in the PICTURE Study. J Urol 2018; 200: 1235-40
Fincham JE. Response rates and responsiveness for surveys, standards, and the journal. Am J Pharm Educ 2008; 1: 43
Morton SM, Bandara DK, Robinson EM, Carr PE. In the 21st Century, what is an acceptable response rate? Aust N Z J Public Health 2012; 36: 106-8
Luscombe CJ, Cooke PW. Pain during prostate biopsy. Lancet 2004; 363: 1840-1
Marra G, Zhuang J, Marquis A et al. Pain in men undergoing transperineal free-hand mpmri fusion-targeted biopsies under local anesthesia: outcomes and predictors from a multicenter study of 1,008 patients. J Urol 2020; 19: e2316
McGrath S, Christidis D, Clarebrough E et al. Transperineal prostate biopsy - tips for analgesia. BJU Int 2017; 120: 164-7